Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pulmonary agents medical

Casualties who improve significantly from one or two MARK I kits given for nerve agent symptoms will continue their mission on improvement. Those casualties who later develop symptoms after vesicant or pulmonary agent exposure will seek medical aid either at the unit aid station or at the BAS. Generally, they will decide to seek assistance before the effects become severe, and they will trans-... [Pg.330]

Any exposure to toxic gases or vapors requires EMS assessment after removal from the laboratory and emergency decontamination. High-flow oxygen and transport to a medical lacffity are indicated. Remember that exposure to some agents such as phosphine may produce delayed problems such as pulmonary edema. Medical evaluation is required for everyone exposed to toxic gases. [Pg.156]

In symptomatic patients, medical therapy can be tailored either to control ventricular response or to restore sinus rhythm. Nondihydropyridine calcium antagonists (e.g., verapamil) are considered first-line drug therapy for decreasing ventricular response. Type I agents (e.g., procainamide, quinidine) are only occasionally effective in restoring sinus rhythm. DCC is ineffective, and /3-blockers are usually contraindicated because of coexisting severe pulmonary disease or uncompensated HF. [Pg.84]

Aerosolised medicines have been used for centuries to treat respiratory diseases, with inhalation therapy for the airways focused primarily on the treatment of asthma and chronic obstructive pulmonary disease (COPD). The development of new products for delivery to the lungs for these respiratory diseases includes new steroids and beta agonists plus combination products featuring both agents. New classes of anti-asthma medication are also being developed for inhalation with the aim of delivering them directly to the inflamed airways. [Pg.239]

This chapter presents the basic pharmacology of the methylxanthines, cromolyn, leukotriene pathway inhibitors, and monoclonal anti-IgE antibody—agents whose medical use is almost exclusively for pulmonary disease. The other classes of drugs previously... [Pg.425]

Occupational medical records should record and document occupationally related medical information of all types (e.g., medical examinations, visits to medical facilities [even for nonoccupational reasons], clinical laboratory data, injuries, pulmonary function tests, audiograms, etc.). The period of time that records must be retained is specified by law depending on the type of data and the health-related agent(s) of concern. In most cases, OSHA requires that information be retained for at least 30 years after the termination of employment (OSHA Standard 29 CFR 1910.1020 Access to Employee Exposure and Medical Records). Medical records should be kept in compliance with the OSHA... [Pg.37]


See other pages where Pulmonary agents medical is mentioned: [Pg.509]    [Pg.486]    [Pg.507]    [Pg.891]    [Pg.892]    [Pg.940]    [Pg.129]    [Pg.105]    [Pg.1025]    [Pg.1051]    [Pg.1055]    [Pg.179]    [Pg.2179]    [Pg.8]    [Pg.45]    [Pg.84]    [Pg.798]    [Pg.27]    [Pg.250]    [Pg.410]    [Pg.287]    [Pg.475]    [Pg.160]    [Pg.198]    [Pg.233]    [Pg.236]    [Pg.243]    [Pg.254]    [Pg.293]    [Pg.365]    [Pg.120]    [Pg.252]    [Pg.1198]    [Pg.112]    [Pg.257]    [Pg.229]    [Pg.966]    [Pg.347]    [Pg.1023]    [Pg.165]    [Pg.112]   
See also in sourсe #XX -- [ Pg.270 ]




SEARCH



Pulmonary agents

© 2024 chempedia.info